Lemalesomab
Lemalesomab
Lemalesomab (pronounced leh-muh-leh-soh-mab) is a monoclonal antibody designed for the treatment of various autoimmune diseases and inflammatory disorders.
Etymology
The name "Lemalesomab" is derived from the International Nonproprietary Names (INN) system for monoclonal antibodies. In this system, "-mab" is a suffix for monoclonal antibodies, "le-" indicates that the drug is a human antibody, and "male-" and "-so-" are substems indicating the drug's targets and disease indications, respectively.
Usage
Lemalesomab is used in the treatment of various autoimmune diseases and inflammatory disorders. It works by binding to specific proteins in the body, blocking their activity and reducing inflammation.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Autoimmune Disease: A condition in which your immune system mistakenly attacks your body.
- Inflammatory Disorder: Conditions characterized by inflammation, including diseases such as rheumatoid arthritis or psoriasis.
Side Effects
Like all medications, Lemalesomab can cause side effects. These may include nausea, headache, fatigue, and rash. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
Precautions
Before starting treatment with Lemalesomab, patients should discuss their full medical history with their healthcare provider. This includes any other medications they are taking, as well as any allergies they may have.
External links
- Medical encyclopedia article on Lemalesomab
- Wikipedia's article - Lemalesomab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski